Ovid Therapeutics
OVID
OVID
88 hedge funds and large institutions have $146M invested in Ovid Therapeutics in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 26 increasing their positions, 22 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
88
Holders Change
+6
Holders Change %
+7.32%
% of All Funds
1.55%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
22
Increased
26
Reduced
22
Closed
15
Calls
$1.25M
Puts
$4.02M
Net Calls
-$2.77M
Net Calls Change
-$2.27M
Top Buyers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$24.5M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$9.98M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$7.62M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$4.52M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.45M |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$4.08M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
-$2.89M |
| 3 |
CA
CHI Advisors
New York
|
-$2.33M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$2.21M |
| 5 |
Renaissance Technologies
New York
|
-$1.64M |
